Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past.…
The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with…
The advent of next-generation sequencing has led to the rise of novel gene expression profiling…
Painstaking and expensive procedures are required to produce human cells for use in research and…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital…
A primary concern in drug development is the binding of drugs to targets they are…
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science…
Vaccines for Covid-19 are rolling out all over the world, but their protection is threatened…
While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide.…
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the…
